Corporate learning platform 360Learning raises $200 million
22 Oct, 2021
– ARTMS received $300,000 funding from Innovate BC.
– The funding will be combined with over $600,000 from additional sources to further develop and validate the production of Zr-89 for use in Positron Emission Tomography (PET) imaging scans of cancer patients eligible for immuno-oncology (IO) therapies.
– “We’re excited to help accelerate game-changing innovation like ARTMS’ proprietary approach to producing critically important, high-quality radiopharmaceutical medical isotopes for cancer patients,” said Mr. Raghwa Gopal, President/CEO of Innovate BC.
– “Past winners have solved critical market problems that other companies have tried to solve for 50 years.”